Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
G. Greg Wang
Professor of Pharmacology and Cancer Biology
Pharmacology & Cancer Biology
greg.wang@duke.edu
3 Genome Court, Box 103057, Durham, NC 27710
MSRB3, 3 Genome Court, Durham, NC 27710
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
Previous Appointments & Affiliations
expertise {hide_children: true, active: false, enabled: false}
Expertise
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
publications {hide_children: true, active: false, enabled: true}
Publications
Selected Publications
artistic-works {hide_children: true, active: false, enabled: false}
Artistic Works / Events
teaching {hide_children: true, active: false, enabled: false}
Teaching
advising-mentoring {hide_children: true, active: false, enabled: false}
Advising & Mentoring
recognition {hide_children: true, active: false, enabled: false}
Recognition
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
Pharmacological Sciences Training Program
Inst. Training Prgm or CME
Preceptor ·
Awarded by National Institutes of Health ·
2025 - 2030
Understanding and targeting epigentic regulation of immune evasion in prostate cancer
Research
Co-Principal Investigator ·
Awarded by National Institutes of Health ·
2025 - 2029
Next-Gen Targeted Therapy in Mantle Cell Lymphoma (MCL) and Transformed Follicular Lymphoma (tFL)
Research
Principal Investigator ·
Awarded by Atrium Health ·
2024 - 2027
The role for phase separation in oncogenesis and aberrant chromatin looping formation
Research
Principal Investigator ·
Awarded by National Institutes of Health ·
2023 - 2027
Discovery of first-in-class WDR5 PROTACS as a novel therapeutic strategy for MLL-rearranged leukemias
Research
Principal Investigator ·
Awarded by Icahn School of Medicine at Mount Sinai ·
2023 - 2027
Dissecting and targeting canonical and non-canonical oncogenic functions of EZH2 in cancer
Research
Principal Investigator ·
Awarded by National Cancer Institute ·
2023 - 2026
A New Histone H3 Modification Regulates Epigenetic Programming and Gene Expression in Breast Cancer
Research
Principal Investigator ·
Awarded by University of Texas Southwestern Medical Center ·
2023 - 2026
The Role of YY1 in Castration-Resistant Prostate Cancer
Research
Co Investigator ·
Awarded by National Cancer Institute ·
2023 - 2026
Targeting histone methyltransferase EZH2 for the treatment of hematological cancer
Fellowship
Principal Investigator ·
Awarded by National Institutes of Health ·
2023 - 2026
Epigenetic therapy of synovial sarcoma: targeting a unique WDR5 dependency by PROTAC
Fellowship
Mentor ·
Awarded by American Association for Cancer Research ·
2024 - 2025
